Management of decompensated cirrhosis due to HbeAg-negative chronic HBV infection with lamivudine monotherapy
JLUMHS-Journal of the Liaquat University of Medical Health Sciences. 2004; 3 (2): 69-73
em Inglês
| IMEMR
| ID: emr-204438
ABSTRACT
Objective:
To evaluate the efficacy of long-term lamivudine monotherapy in patients with decompensated cirrhosis due to HbeAg-negative1HBV-DNA positive.Design:
Case - control study.Setting:
Departments of Medicine and Surgery, Liaquat University Hospital, Jamshoro, and Isra University Hospital Hyderabad, from March 2000 to June 2003
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
J. Liaquat Univ. Med. Health Sci.
Ano de publicação:
2004
Similares
MEDLINE
...
LILACS
LIS